Spironolactone Suspension
Product Images NDC 31722-691

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 31722-691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

118ml-container-label (118ml Container Label)

118ml-container-label (118ml Container Label)
This text provides information about a medication called Spironolactone Oral Suspension, with a dosage of 25 mg/5 mL. It includes details on usage instructions, storage conditions, and manufacturer information. The medication is dispensed in a tight container to ensure effectiveness. Keep out of reach of children. The contact number for the US is provided for queries. The medication is manufactured by Hetero Labs Limited in India for Camber Pharmaceuticals, Inc.*
FDA Label Image

473ml-container-label (473ml Container Label)

473ml-container-label (473ml Container Label)
This text is a label for Spironolactone Oral Suspension, containing 25 mg of Spironolactone per 5 mL. It provides instructions for use, storage, usual dosage, contact information, and the manufacturer details for Gamber Pharmaceuticals and Hetero Labs Limited in India.*
FDA Label Image
FDA Label Image

Spironolactone-figure-1 (Spironolactone Figure 1)

FDA Label Image

Spironolactone-structure (Spironolactone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.